Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 340,351 | 214,873 | 184,612 | 142,162 | 104,419 |
| Marketable Securities | N/A | 199,983 | 228,521 | 156,756 | 241,995 |
| Receivables | 324,451 | 146,490 | 112,993 | 92,249 | 153,773 |
| Inventories | 125,582 | 80,570 | 70,107 | 89,764 | 54,177 |
| Income taxes - deferred | N/A | N/A | 50,788 | 42,529 | 37,853 |
| TOTAL | $822,073 | $675,626 | $659,742 | $545,543 | $599,935 |
| Non-Current Assets | |||||
| PPE Net | 214,156 | 188,169 | 188,191 | 180,758 | 118,158 |
| Intangibles | 812,186 | 54,285 | 57,244 | 75,524 | 29,824 |
| Other Non-Current Assets | 74,072 | 161,117 | 91,746 | 62,145 | 45,942 |
| TOTAL | $1,100,414 | $403,571 | $337,181 | $318,427 | $193,924 |
| Total Assets | $1,922,487 | $1,079,197 | $996,923 | $863,970 | $793,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 56,325 | 31,976 | 26,824 | 41,340 | 22,955 |
| Accrued Expenses | 270,436 | 125,816 | 123,083 | 97,678 | 110,882 |
| TOTAL | $326,761 | $158,699 | $153,890 | $145,295 | $156,861 |
| Non-Current Liabilities | |||||
| Long Term Debt | 424,595 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | 907 | 3,983 | 6,277 | 23,024 |
| Other Non-Current Liabilities | 35,952 | 29,218 | 28,563 | 21,210 | 16,926 |
| TOTAL | $533,317 | $32,621 | $32,830 | $27,572 | $34,057 |
| Total Liabilities | $860,078 | $191,320 | $186,720 | $172,867 | $190,918 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,603 | 71,330 | 69,748 | 68,460 | 66,808 |
| Common Shares | 729 | 714 | 699 | 685 | 667 |
| Retained earnings | 570,223 | 531,226 | 473,873 | 372,614 | 316,741 |
| Other shareholders' equity | -10,620 | -6,166 | 983 | 5,087 | 1,567 |
| TOTAL | $1,062,409 | $887,877 | $810,203 | $691,103 | $602,941 |
| Total Liabilities And Equity | $1,922,487 | $1,079,197 | $996,923 | $863,970 | $793,859 |